Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CNTB
Stock Latest News
The Fly
Connect Biopharma files to sell 6.13M ordinary shares for holders
4d ago
CNTB
Premium
Ratings
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
6d ago
CNTB
Premium
The Fly
Connect Biopharma reports Q1 EPS (34c), consensus (28c)
7d ago
CNTB
Premium
Company Announcements
Connect Biopharma Advances Rademikibart After Positive Interim Review
26d ago
8K
CNTB
Premium
The Fly
Connect Biopharma announces enrollment in Seabreeze STAT study
26d ago
CNTB
Premium
The Fly
Connect Biopharma director buys $4.0M in common stock
2M ago
CNTB
Premium
Ratings
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
2M ago
CNTB
Premium
Ratings
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
2M ago
CNTB
Premium
Company Announcements
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
2M ago
8K
CNTB
Premium
The Fly
Connect Biopharma announces results from rademikibart study
2M ago
CNTB
Premium
Pre-Earnings
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CNTB
Premium
The Fly
Connect Biopharma highlights new mechanism of action data for rademikibart
4M ago
CNTB
Premium
The Fly
H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma
4M ago
ACHV
CNTB
Premium
Company Announcements
Connect Biopharma announces board resignation amid U.S. transition
5M ago
8K
CNTB
Premium
The Fly
Connect Biopharma initiated with a Buy at Lake Street
6M ago
CNTB
Premium
Company Announcements
Connect Biopharma Reports Significant Loss Amid Development Efforts
6M ago
CNTB
Premium
Ratings
Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships
6M ago
CNTB
Premium
Ratings
Buy Rating for Connect Biopharma Holdings: Rademikibart’s Market Differentiation and Safety Advantages
6M ago
CNTB
Premium
The Fly
Connect Biopharma reports Q3 EPS (31c), consensus (24c)
6M ago
CNTB
Premium
Ratings
Promising Outlook for Connect Biopharma Holdings: Rademikibart’s Potential in Asthma and COPD
7M ago
CNTB
Premium
The Fly
Connect Biopharma initiated with a Buy at BTIG
7M ago
CNTB
Premium
Ratings
Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart
8M ago
CNTB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
